BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:04 PM
 | 
Jul 06, 2009
 |  BC Extra  |  Company News

Companies say FDA seeking Gaucher's submissions

Protalix Biotherapeutics Inc. (NYSE-A:PLX) and Shire plc (LSE:SHP; NASDAQ:SHPGY) said FDA requested treatment protocols for the use of investigative products to treat Gaucher's disease to address an expected shortage of Cerezyme imiglucerase from Genzyme Corp. (NASDAQ:GENZ)....

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >